Atrial appendage transcriptional profile in patients with atrial fibrillation with structural heart diseases

Annals of the New York Academy of Sciences

Volumn 1091, Issue , 2006, Pages 205-217

  Kharlap, Maria S ^a   Timofeeva, Angelica V ^a   Goryunova, Ludmila E ^a   Khaspekov, George L ^a   Dzemeshkevich, Sergey L ^a   Ruskin, Vladimir V ^a   Akchurin, Renat S ^a   Golitsyn, Sergey P ^a   Beabealashvilli, Robert Sh ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

Atrial fibrillation; cDNA microarray; RT PCR

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; COMPLEMENTARY DNA; MEGAKARYOCYTE STIMULATING FACTOR; NEURON DERIVED ORPHAN RECEPTOR 1; PROTEIN; PROTEIN BCL 2; UNCLASSIFIED DRUG; MESSENGER RNA;

ADULT; APOPTOSIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HUMAN; HUMAN TISSUE; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE PREPARATION; TRANSCRIPTION REGULATION; AGED; ARTICLE; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 33947591343     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1378.067     Document Type: Conference Paper

References (35)

1. TIELEMAN, R.G. 2003. The pathophysiology of maintenance of atrial fibrillation. Pacing. Clin. Electrophysiol. 26: 1569-1571.
2. SCHOONDERWOERD, B.A., I.C. VAN GELDER, D.J. VAN V ELDHUISEN, et al. 2005. Electrical and structural remodeling: role in the genesis and maintenance of atrial fibrillation. Prog. Cardiovasc. Dis. 48: 153-168.
3. VAN WAGONER, D.R., A.L. POND, P.M. MC CARTHY, et al. 1997. Outward K current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ. Res. 80: 772-781.
4. BRUNDEL, B.J., I.C. VAN GELDER, R.H. HENNING, et al. 2001. Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K channels. J. Am. Coll. Cardiol. 37: 926-932.
5. BRUNDEL, B.J., I.C. VAN GELDER, R.H. HENNING, et al. 1999. Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. Cardiovasc. Res. 42: 443-454.
6. LAI, L.P., M.J. SU, J.L. LIN, et al. 1999. Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into mechanism of atrial electrical remodeling. J. Am. Coll. Cardiol. 33: 1231-1237.
7. BRUNDEL, B.J., R.H. HENNING, H.H. KAMPINGA, et al. 2002. Molecular mechanisms of remodeling in human atrial fibrillation. Cardiovasc. Res. 54: 315-324.
8. LAMIRAULT, G., N. GABORIT, N. LE MEUR, et al. 2006. Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man. J. Mol. Cell. Cardiol. 40: 173-184.
9. LAI, L.P., J.L. LIN & C.S. LIN. 2004. Functional genomic study on atrial fibrillation using cDNA microarray and two-dimensional protein electrophoresis techniques and identification of the myosin regulatory light chain isoform reprogramming in atrial fibrillation. J. Cardiovasc. Electrophysiol. 15: 214-223.
10. OHKI, R., K. YAMAMOTO, S. UENO, et al. 2005. Gene expression profiling of human atrial myocardium with atrial fibrillation by DNA microarray analysis. Int. J. Cardiol. 102: 233-238.
11. KIM, Y.H., S. LIM DO, J.H. LEE, et al. 2003. Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp. Mol. Med. 35: 336-349.
12. KIM, N.-H., Y. AHN, S.K. OH, et al. 2005. Altered patterns of gene expression in response to chronic atrial fibrillation. Int. Heart J. 46: 383-395.
13. BARTH, A.S., S. MERK, E. ARNOLDI, et al. 2005. Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature. Circ. Res. 96: 1022-1029.
14. OHKI-KANEDA, R., J. OHASHI, K. YAMAMOTO, et al. 2004. Cardiac function-related gene expression profiles in human atrial myocytes. Biochem. Biophys. Res. Commun. 320: 1328-1336.
15. MILBRANDT, J. 1988. Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron 1: 183-188.
16. YOON, J.K. & L.F. LAU. 1993. Transcriptional activation of the inducible nuclear receptor gene nur77 by nerve growth factor and membrane depolarization in PC12 cells. J. Biol. Chem. 268: 9148-9155.
17. PEI, L. & A. CASTRILLO. 2005. Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77. Mol. Endocrin. 8 : Epub.
18. LIU, D., H. JIA, D.I.R. HOLMES, et al. 2003. Vascular endothelial growth factor-regulated gene expression in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 23: 2002-2007.
19. MAXWELL, M.A., M.E. CLEASBY, A. HARDING, et al. 2005. Nurr77 regulates lipolysis in skeletal muscle cells. J. Biol. Chem. 280: 12573-12584.
20. LIN, E.Y., A. ORLOFSKY, H-G. WANG, et al. 1996. A1, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation. Blood 87: 983-992.
21. TAEGTMEYER, H., C.R. WILSON, P. RAZEGHI, et al. 2005. Metabolic energetics and genetics in the heart. Ann. N. Y. Acad. Sci. 1047: 208-218.
22. HE, C-H., A.B. WAXMAN, C.G. LEE, et al. 2005. Bcl-2-related protein A1 is an endogenous and cytokine-stimulated mediator of cytoprotaction in hyperoxic acute lung injury. J. Clin. Invest. 115: 1039-1048.
23. WILKER, E.W., R.A. GRANT, S.C. ARTIM, et al. 2005. A structural basis for 14-3-3σ functional specificity. J. Biol. Chem. 280: 18891-18898.
24. CHAN, T.A., H. HERMEKING, C. LENGAUER, et al. 1999. 14-3-3σ is required to prevent mitotic catastrophe after DNA damage. Nature 7: 535-537.
25. KAGAN, A., Y.F. MELMAN, A. KRUMERMAN, et al. 2002. 14-3-3 amplifies and prolongs adrenergic stimulation of HERG K channel activity. EMBO J. 21: 1889-1898.
26. KAGAN, A. & T.V. MCDONALD. 2005. Dynamic control of HERG/I(Kr) by PKA-mediated interactions with 14-3-3. Novartis Found. Symp. 266: 75-89 [discussion 89-99].
27. XING, H.S. ZHANG, C. WEINHEIMER, et al. 2000. 14-3-3 Proteins block apoptosis and differentially regulate MAPK cascades. EMBO J. 19: 349-358.
28. STOECKLIN, G., T. STUBBS, N. KEDERSHA, et al. 2004. MK2-induced tristetraprolin: 14-3-3 complexes prevent stress granule association and ARE-mRNA. EMBO J. 23: 1313-1324.
29. BLACKSHEAR, P.J., W.S. LAI, E.A. KENNINGTON, et al. 2003. Characteristics of the interaction of a synthetic human tristetraprolin tandem zinc finger peptide with AU-rich element-containing RNA substrates. J. Biol. Chem. 278: 19947-19955.
30. HONMA, S., T. KAWAMOTO, Y. TAKAGI, et al. 2002. Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature 419: 841-844.
31. YOUNG, M.E., P. RAZEGHI, A.M. CEDARS, et al. 2001. Intrinsic diurnal variations in cardiac metabolism and contractile function. Circ. Res. 89: 1199-1208.
32. DURGAN, D.J., M.A. HOTZE & T.M. TOMLIN. 2005. The intrinsic circadian clock within the cardiomyocyte. Am. J. Physiol. Heart Circ. Physiol. 289: H1530-H1541. Epub.
33. SHEIKH-HAMAD, D., R. BICK, GANG-YI WU, et al. 2003. Stanniocalcin-1 is a naturally occuring L-channel inhibitor in cardiomyocytes: relevance to human heart failure. Am. J. Physiol. Heart Circ. Physiol. 285: H442-H448.
34. ZHANG, K., P.J. LINDSBERG, T. TATLISUMAK, et al. 2000. Stanniocalcin: a molecular guard of neurons during cerebral ishemia. Proc. Nat. Acad. Sci. USA 97: 3637-3642.
35. KANELLIS, J., R. BICK, G. GARCIA, et al. 2003. Stanniocalcin-1, an inhibitor of macrophage chemotaxis and chemokinesis. Am. J. Physiol. 286: F356-F362.